Orange, California
Colorectal cancer clinical trials in Orange, CA
23 colorectal cancer studies are recruiting participants at sites in Orange as of November 16, 2026, according to ClinicalTrials.gov. Colorectal Cancer Clinical Trials can help you understand your options and connect with a study team.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Orange at a glance
- 23 studies are recruiting at a site in Orange.
- By phase: Phase 1 (6), Phase 1/2 (7), Phase 2 (5), Phase 2/3 (2), Phase 3 (2), Observational (1).
- By sponsor: industry (11), university, hospital or other (8), government (4).
- Most recent update to one of these records: November 16, 2026.
Studies recruiting in Orange
Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Boehringer Ingelheim
- Study site
- University of California Irvine
- Registry record
- NCT06324357 · updated
A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Astellas Pharma Global Development, Inc.
- Study site
- UC Irvine Health-Chao Family Comprehensive Cancer Center
- Registry record
- NCT07488676 · updated
Testing the Addition of Anti-cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment, Cetuximab Plus Encorafenib, for Colorectal Cancer
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Study site
- UC Irvine Health/Chao Family Comprehensive Cancer Center
- Registry record
- NCT06102902 · updated
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Summit Therapeutics
- Registry record
- NCT07228832 · updated
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
- Phase 2/3
- Ages 18 and older
- All sexes
- Sponsor
- NRG Oncology
- Study site
- Saint Joseph Hospital - Orange
- Registry record
- NCT05174169 · updated
Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Alliance for Clinical Trials in Oncology
- Study site
- UC Irvine Health/Chao Family Comprehensive Cancer Center
- Registry record
- NCT05673148 · updated
Testing the Addition of an Anti-Cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment (Capecitabine) for Metastatic or Unresectable Cancers
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Study site
- UC Irvine Health/Chao Family Comprehensive Cancer Center
- Registry record
- NCT05803382 · updated
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
- Phase 2/3
- Ages 18 and older
- All sexes
- Sponsor
- Bristol-Myers Squibb
- Study site
- University of California, Irvine (UCI) Health - UC Irvine Medical Center
- Registry record
- NCT07221357 · updated
Testing the Addition of an Anti-Cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (5-Fluorouracil) for Metastatic, Refractory Colorectal Cancer
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Study site
- UC Irvine Health/Chao Family Comprehensive Cancer Center
- Registry record
- NCT06654037 · updated
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Revolution Medicines, Inc.
- Study site
- UC IRVINE Health
- Registry record
- NCT06128551 · updated
Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas
- Phase 1
- Ages 12 to 85
- All sexes
- Sponsor
- Inhibrx Biosciences, Inc
- Study site
- Children's Hospital of Orange County-Rady Children's Health
- Registry record
- NCT03715933 · updated
Ph II Intraperitoneal Paclitaxel + System Therapy in GI Ca w/Peritoneal Carcinomatosis (STOPGAP-B)
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- University of California, Irvine
- Study site
- Chao Family Comprehensive Cancer Center, University of California, Irvine
- Registry record
- NCT07795749 · updated
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
- Phase 1/2
- From 12 months, up to 30 years
- All sexes
- Sponsor
- Children's Oncology Group
- Study site
- Children's Hospital of Orange County
- Registry record
- NCT04851119 · updated
Testing the Combination of the Anti-Cancer Drugs Temozolomide and M1774 to Evaluate Their Safety and Effectiveness
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Study site
- UC Irvine Health/Chao Family Comprehensive Cancer Center
- Registry record
- NCT05691491 · updated
Neoadjuvant Chemotherapy, Excision And Observation vs Chemoradiotherapy For Rectal Cancer
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Canadian Cancer Trials Group
- Study site
- UC Irvine Health/Chao Family Comprehensive Cancer Center
- Registry record
- NCT06205485 · updated
Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- University of California, Irvine
- Study site
- Chao Family Comprehensive Cancer Center, University of California Irvine
- Registry record
- NCT06580002 · updated
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Revolution Medicines, Inc.
- Study site
- UC Irvine/Chao Family Comprehensive Cancer Center
- Registry record
- NCT05379985 · updated
Study of ctDNA Guided Change in Tx for Refractory Minimal Residual Disease in Colon Adenocarcinomas
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- University of California, Irvine
- Study site
- Chao Family Comprehensive Cancer Center, University of California, Irvine
- Registry record
- NCT04920032 · updated
TATE and Pembrolizumab (MK3475) in mCRC and NSCLC
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Teclison Ltd.
- Study site
- University of California, Irvine Medical Center
- Registry record
- NCT04701476 · updated
A Study of VET3-TGI in Patients With Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- KaliVir Immunotherapeutics
- Study site
- UC Irvine Health
- Registry record
- NCT06444815 · updated
Riluzole For Preventing Cognitive Dysfunction in Ca Pts Receiving Chemo (REFOCUS): Pilot Trial
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- University of California, Irvine
- Study site
- Chao Family Comprehensive Cancer Center, University of California Irvine
- Registry record
- NCT07447050 · updated
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Observational
- All ages
- All sexes
- Sponsor
- Massive Bio, Inc.
- Study site
- Massive Bio SYNERGY-AI site
- Registry record
- NCT03452774 · updated
64Cu-LNTH-1363S in Patients With Sarcoma or Gastrointestinal Tract Cancer
- Phase 1/2
- Ages 15 and older
- All sexes
- Sponsor
- Lantheus Medical Imaging
- Study site
- UC Irvine Health - Chao Family Comprehensive Cancer Center
- Registry record
- NCT06298916 · updated
Source: ClinicalTrials.gov. Data processed . See every colorectal cancer study recruiting in Orange, CA on ClinicalTrials.gov.
Ask about studies near Orange
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
More locations in California
All California locations
193 studies recruiting across 110 cities.
Los Angeles
92 studies recruiting.
Duarte
50 studies recruiting.
San Francisco
29 studies recruiting.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.
Colorectal Cancer Clinical Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections